adding therapeutic value


Harmonic Pharma has developped a unique approach to find new uses of safe drugs and natural extracts : polypharmacology. Our expertise is a powerful accelerator of R&D: as the toxicity is already thoroughly documented in the original indication, development will be less risky and access to market will be faster in the proposed novel use.

Today, Harmonic Pharma focuses its expertise on respiratory health through respiratory wellness and lung cancer.

Michel Souchet – CEO

about polypharmacology

Polypharmacology dedicated to respiratory health


harmonic pharma

Harmonic Pharma is the very first company developing and applying the polypharmacology paradigm to respiratory health. The expertise of the company results from a breakthrough innovation combined with the use of safe drugs and compounds.

About us


Since inception in 2009, Harmonic Pharma has successfully managed several million euros R&D programs, including the development of assets which have been patented in the field of respiratory health and are ready to be licensed out :

Lung cancer : An asset for Non Small Cell Lung Cancer (in monotherapy and/or in combination with existing treatments).
Respiratory wellness : One natural extract from the Vosges forests.

Read more



27 July 2015

The Galien Foundation and Business France guide and reward French-American partnerships in the field of health with the MedStartUp Days 2015 program. Harmonic...
learn more

& partners

Investment key factors:

  • An active worldwide market seeking innovations.
  • A innovative know-how recognized internationally.
  • A proprietary technology providing access to therapeutic areas.
  • A robust R&D through strategic partners.
  • An experienced team with complementary backgrounds.

join us